Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XBI with:
  • Price/Earnings ttm 10.18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.040 on 03/22/21
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 41.50% ( -1.49%)
  • Historical Volatility 44.71%
  • IV Percentile 52%
  • IV Rank 41.47%
  • IV High 65.31% on 05/09/22
  • IV Low 24.63% on 10/22/21
  • Put/Call Vol Ratio 2.16
  • Today's Volume 44,478
  • Volume Avg (30-Day) 58,753
  • Put/Call OI Ratio 1.07
  • Today's Open Interest 993,514
  • Open Int (30-Day) 885,330

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.72 +19.13%
on 08/02/22
95.18 -1.47%
on 08/11/22
+11.91 (+14.55%)
since 07/12/22
3-Month
62.13 +50.94%
on 06/14/22
95.18 -1.47%
on 08/11/22
+28.87 (+44.48%)
since 05/12/22
52-Week
61.78 +51.80%
on 05/12/22
136.61 -31.35%
on 09/02/21
-33.01 (-26.04%)
since 08/12/21

Most Recent Stories

More News
Why Shares of Co-Diagnostics Stock Fell 10% on Tuesday

The stock dropped two days before reporting second-quarter earnings.

CODX : 4.48 (-30.65%)
XBI : 93.78 (+3.30%)
Biotech Wins Last Week: 5 Best ETFs

The biotech corner of the broad healthcare sector outperformed last week on speculation over a takeover bid for Global Blood Therapeutics.

PFE : 50.11 (+3.77%)
GBT : 66.75 (+0.27%)
BBC : 28.63 (+4.95%)
XBI : 93.78 (+3.30%)
SBIO : 35.03 (+3.34%)
BBP : 49.74 (+1.49%)
Should You Buy Beaten-Down Biotech Stocks & ETFs?

We highlight 4 ETFs that have started rebounding after a brutal sell-off

AMGN : 248.39 (+0.02%)
GILD : 62.96 (+0.82%)
VRTX : 294.52 (+0.81%)
IBB : 132.52 (+0.94%)
TDOC : 40.32 (+6.13%)
XBI : 93.78 (+3.30%)
CRSP : 78.66 (+1.55%)
ARKG : 41.91 (+3.61%)
IBBQ : 21.14 (+1.15%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 66.02 (+1.09%)
BIIB : 220.99 (+1.27%)
VRTX : 294.52 (+0.81%)
IBB : 132.52 (+0.94%)
CTLT : 109.97 (+0.03%)
XBI : 93.78 (+3.30%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 93.78 (+3.30%)
IBB : 132.52 (+0.94%)
FATE : 33.82 (+3.58%)
FBT : 147.90 (+0.78%)
IOVA : 12.66 (+6.93%)
TWST : 52.97 (+7.93%)
Is It Time to Buy the Dip With Biotech Stocks?

Right now, it's even riskier to buy biotechs than normal.

XBI : 93.78 (+3.30%)
NTLA : 67.74 (+3.26%)
Has the Market Bottomed? 6 ETFs in High Momentum

These ETFs are in high momentum as some traders believe that markets have reached a bottom.

RTH : 176.13 (+1.63%)
ITB : 62.91 (+1.47%)
XBI : 93.78 (+3.30%)
FUTY : 49.44 (+1.69%)
KBWD : 18.42 (+0.93%)
DAT : 27.63 (+1.77%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 160.48 (+0.10%)
AMGN : 248.39 (+0.02%)
GILD : 62.96 (+0.82%)
VRTX : 294.52 (+0.81%)
IBB : 132.52 (+0.94%)
XBI : 93.78 (+3.30%)
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

FBT : 147.90 (+0.78%)
EXEL : 19.48 (+1.30%)
IBB : 132.52 (+0.94%)
NBIX : 105.63 (+0.72%)
SRPT : 109.00 (-0.24%)
XBI : 93.78 (+3.30%)
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Smart Beta ETF report for IBB

IBB : 132.52 (+0.94%)
REGN : 628.71 (+0.77%)
AMGN : 248.39 (+0.02%)
GILD : 62.96 (+0.82%)
XBI : 93.78 (+3.30%)
FBT : 147.90 (+0.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 97.57
2nd Resistance Point 95.84
1st Resistance Point 94.81
Last Price 93.78
1st Support Level 92.05
2nd Support Level 90.32
3rd Support Level 89.29

See More

52-Week High 136.61
Fibonacci 61.8% 108.02
Fibonacci 50% 99.19
Last Price 93.78
Fibonacci 38.2% 90.37
52-Week Low 61.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar